Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM, Greig NH, Khan TA, Hassan I, Tabrez S, Shakil S, Sheikh IA, Zaidi SK, Akram M, Jabir NR, Firoz CK, Naeem A, Alhazza IM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014;13(7):1280-93.
Similar articles
Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus.
Mirza Z, Ali A, Ashraf GM, Kamal MA, Abuzenadah AM, Choudhary AG, Damanhouri GA, Sheikh IA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):213-25. Review.
Genomic linkage between Alzheimer's disease and type 2 diabetes.
Nedjadi T, Haque A, Alam Q, Gan SH, Chaudhary AG, Abuzenadah AM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):203-12. Review.
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.
Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409. Review.
A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes.
Alam Q, ZubairAlam M, Karim S, Gan SH, Kamal MA, Jiman-Fatani A, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Haque A.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):478-86. Review.
Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase.
Priyadarshini M, Kamal MA, Greig NH, Reale M, Abuzenadah AM, Chaudhary AG, Damanhouri GA.
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):482-9. Review.
Molecular interaction of the antineoplastic drug, methotrexate with human brain acetylcholinesterase: a docking study.
Shakil S, Kamal MA, Tabrez S, Abuzenadah AM, Chaudhary AG, Damanhouri GA.
CNS Neurol Disord Drug Targets. 2012 Mar;11(2):142-7.
An overview on the correlation of neurological disorders with cardiovascular disease.
Firoz CK, Jabir NR, Khan MS, Mahmoud M, Shakil S, Damanhouri GA, Zaidi SK, Tabrez S, Kamal MA.
Saudi J Biol Sci. 2015 Jan;22(1):19-23. doi: 10.1016/j.sjbs.2014.09.003. Epub 2014 Sep 6. Review.
Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.
Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, Haque A.
Curr Pharm Des. 2016;22(5):541-8. Review.
The role of viruses in neurodegenerative and neurobehavioral diseases.
Karim S, Mirza Z, Kamal MA, Abuzenadah AM, Azhar EI, Al-Qahtani MH, Damanhouri GA, Ahmad F, Gan SH, Sohrab SS.
CNS Neurol Disord Drug Targets. 2014;13(7):1213-23. Review.
Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.
Ali A, Sheikh IA, Mirza Z, Gan SH, Kamal MA, Abuzenadah AM, Damanhouri GA, Ashraf GM.
Curr Drug Metab. 2015;16(5):376-88. Review.
Altered galectin glycosylation: potential factor for the diagnostics and therapeutics of various cardiovascular and neurological disorders.
Ashraf GM, Perveen A, Tabrez S, Jabir NR, Damanhouri GA, Zaidi SK, Banu N.
Adv Exp Med Biol. 2015;822:67-84. doi: 10.1007/978-3-319-08927-0_10.
Nanotechnology-based approaches in anticancer research.
Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA.
Int J Nanomedicine. 2012;7:4391-408. doi: 10.2147/IJN.S33838. Epub 2012 Aug 9. Review.
Estimation of Interleukin-1β Promoter (-31 C/T and -511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients.
Tabrez S, Jabir NR, Firoz CK, Hindawi S, Shakil S, Damanhouri GA, Zaidi SK.
J Cell Biochem. 2017 Sep;118(9):2977-2982. doi: 10.1002/jcb.25958. Epub 2017 Apr 12.
A putative association of interleukin-10 promoter polymorphisms with cardiovascular disease.
Tabrez S, Ali M, Jabir NR, Firoz CK, Ashraf GM, Hindawi S, Damanhouri GA, Nabil Alama M.
IUBMB Life. 2017 Jul;69(7):522-527. doi: 10.1002/iub.1637. Epub 2017 May 5.
Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers.
Firoz CK, Jabir NR, Kamal MA, Alama MN, Damanhouri GA, Khan W, Alzahrani AS, Almehdar HA, Tabrez S.
IUBMB Life. 2015 Jun;67(6):453-9. doi: 10.1002/iub.1390. Epub 2015 Jun 18.
Cancer chemoprevention by polyphenols and their potential application as nanomedicine.
Tabrez S, Priyadarshini M, Urooj M, Shakil S, Ashraf GM, Khan MS, Kamal MA, Alam Q, Jabir NR, Abuzenadah AM, Chaudhary AG, Damanhouri GA.
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31(1):67-98. doi: 10.1080/10590501.2013.763577. Review.
Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients.
Jabir NR, Firoz CK, Kamal MA, Damanhouri GA, Alama MN, Alzahrani AS, Almehdar HA, Tabrez S.
J Clin Lab Anal. 2017 Sep;31(5). doi: 10.1002/jcla.22092. Epub 2016 Nov 9.
Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.
Jabir NR, Firoz CK, Ahmed F, Kamal MA, Hindawi S, Damanhouri GA, Almehdar HA, Tabrez S.
Immunol Invest. 2017 Jul;46(5):526-535. doi: 10.1080/08820139.2017.1306866. Epub 2017 Apr 17.
Assessment of IL-18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients.
Jabir NR, Firoz CK, Kamal MA, Damanhouri GA, Alama MN, Alam Q, Haque A, Almehdar HA, Tabrez S.
J Cell Biochem. 2017 Jul;118(7):1849-1854. doi: 10.1002/jcb.25870. Epub 2017 Feb 16.
Filters: Manage Filters